Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Basis of Fibromuscular Dysplasia: The Define-FMD Study

NCT01967511 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT01967511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01967511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Basis of Fibromuscular Dysplasia: The Define-FMD Study
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2013
Completion date
December 31, 2030
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical artery dissection, fibromuscular dysplasia, spontaneous coronary artery dissection